Point72 Asia Singapore Pte. Ltd. Sells 1,195 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Point72 Asia Singapore Pte. Ltd. lessened its stake in Addus HomeCare Co. (NASDAQ:ADUS) by 71.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 467 shares of the company’s stock after selling 1,195 shares during the period. Point72 Asia Singapore Pte. Ltd.’s holdings in Addus HomeCare were worth $54,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in ADUS. Trexquant Investment LP acquired a new position in Addus HomeCare in the fourth quarter valued at about $271,000. US Bancorp DE raised its stake in shares of Addus HomeCare by 177.6% during the fourth quarter. US Bancorp DE now owns 8,598 shares of the company’s stock worth $798,000 after buying an additional 5,501 shares during the last quarter. Allianz Asset Management GmbH bought a new stake in Addus HomeCare in the fourth quarter valued at about $5,667,000. Dean Capital Management acquired a new position in Addus HomeCare during the fourth quarter valued at approximately $652,000. Finally, Virtu Financial LLC bought a new position in Addus HomeCare during the fourth quarter worth about $322,000. 95.35% of the stock is owned by institutional investors and hedge funds.

Addus HomeCare Price Performance

Shares of Addus HomeCare stock opened at $133.03 on Tuesday. Addus HomeCare Co. has a one year low of $78.35 and a one year high of $136.12. The stock’s 50-day moving average is $128.48 and its 200 day moving average is $115.67. The firm has a market cap of $2.41 billion, a price-to-earnings ratio of 33.01, a PEG ratio of 2.40 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, August 5th. The company reported $1.35 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.14. The business had revenue of $286.90 million for the quarter, compared to analysts’ expectations of $284.90 million. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. The firm’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter last year, the firm earned $0.94 EPS. On average, sell-side analysts expect that Addus HomeCare Co. will post 4.58 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. TD Cowen increased their price objective on Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a report on Thursday, August 8th. Macquarie assumed coverage on Addus HomeCare in a research note on Friday, June 28th. They set an “outperform” rating and a $136.00 price objective on the stock. StockNews.com downgraded shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Sunday, July 7th. Stephens reissued an “overweight” rating and set a $138.00 target price on shares of Addus HomeCare in a research note on Tuesday, August 6th. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $141.00 price objective on shares of Addus HomeCare in a report on Tuesday, September 3rd. One research analyst has rated the stock with a sell rating and eight have issued a buy rating to the company. Based on data from MarketBeat, Addus HomeCare currently has a consensus rating of “Moderate Buy” and a consensus target price of $128.29.

Insiders Place Their Bets

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the sale, the executive vice president now directly owns 7,215 shares of the company’s stock, valued at $961,687.35. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total transaction of $63,750.00. Following the completion of the sale, the director now directly owns 3,366 shares in the company, valued at $429,165. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the transaction, the executive vice president now owns 7,215 shares in the company, valued at $961,687.35. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 22,917 shares of company stock valued at $3,050,082. Insiders own 4.60% of the company’s stock.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.